Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biological treatment in allergic disease.
Shamji MH, Palmer E, Layhadi JA, Moraes TJ, Eiwegger T. Shamji MH, et al. Among authors: palmer e. Allergy. 2021 Sep;76(9):2934-2937. doi: 10.1111/all.14954. Epub 2021 Jun 12. Allergy. 2021. PMID: 34028048 No abstract available.
Molecular allergology approach to allergic asthma.
Agache I, Palmer E, Sanver D, Kirtland M, Shamji MH. Agache I, et al. Among authors: palmer e. Mol Aspects Med. 2022 Jun;85:101027. doi: 10.1016/j.mam.2021.101027. Epub 2021 Sep 25. Mol Aspects Med. 2022. PMID: 34579961 Review.
COVID-19  vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations.
Jutel M, Torres MJ, Palomares O, Akdis CA, Eiwegger T, Untersmayr E, Barber D, Zemelka-Wiacek M, Kosowska A, Palmer E, Vieths S, Mahler V, Canonica WG, Nadeau K, Shamji MH, Agache I. Jutel M, et al. Among authors: palmer e. Allergy. 2022 Aug;77(8):2313-2336. doi: 10.1111/all.15252. Epub 2022 Mar 18. Allergy. 2022. PMID: 35147230 Free PMC article.
Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis.
Eguiluz-Gracia I, Parkin RV, Layhadi JA, Palmer E, Meng X, Zhu R, Sahiner U, Durham SR, Torres MJ, Mayorga C, Rondon C, Shamji MH. Eguiluz-Gracia I, et al. Among authors: palmer e. Allergy. 2024 Aug;79(8):2197-2206. doi: 10.1111/all.16083. Epub 2024 Mar 14. Allergy. 2024. PMID: 38483174 Clinical Trial.
Ara h 2-expressing cucumber mosaic virus-like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals.
Layhadi JA, Starchenka S, De Kam PJ, Palmer E, Patel N, Keane ST, Hikmawati P, Drazdauskaite G, Wu LYD, Filipaviciute P, Parkin RV, Oluwayi K, Rusyn O, Skinner MA, Heath MD, Hewings SJ, Kramer MF, Turner P, Shamji MH. Layhadi JA, et al. Among authors: palmer e. J Allergy Clin Immunol. 2025 Jan;155(1):153-165. doi: 10.1016/j.jaci.2024.08.010. J Allergy Clin Immunol. 2025. PMID: 39756833
1,375 results